Dr Louise Linsell
Lead Medical Statistician
Louise joined the NPEU Clinical Trials Unit in 2009 and leads on the design, conduct, analysis and reporting of a portfolio of neonatal and obstetric clinical trials. She manages a team of statisticians and is responsible for all matters related to statistics and methodology. She is a co-investigator on a number of recent grants awarded to the unit and teaches on the MSc in Global Health in the Nuffield Department of Population Health. In 2012 she was awarded a National Institute of Health Research (NIHR) Research Doctoral Fellowship to undertake a DPhil on the neurodevelopment of extremely preterm infants with the EPICURE group at University College London.
Louise graduated with a BSc (Hons) in Mathematics and Statistics at Newcastle University in 1996, followed by a MSc in Medical Statistics at Leicester University in 1997, and since then has held several research posts. In her first post at the London School of Hygiene and Tropical Medicine, she worked on a vitamin A supplementation trial based in Ghana and a study investigating the causes and transmission of new variant Creutzfeldt Jakob disease, and also contributed to the post-graduate teaching programme. Following this she spent over a year working as a statistician at the Medical Research Council (MRC) Sickle Cell Unit in Jamaica, and as a lecturer at the University of the West Indies. Louise joined the Department of Public Health at Oxford University in 2002 and since then has worked on a variety of epidemiology studies and clinical trials within the University.
Enteral lactoferrin supplementation for very preterm infants: a randomised placebo-controlled trial.
ELFIN trial investigators group None., (2019), Lancet, 393, 423 - 433
Planned delivery or expectant management for late preterm pre-eclampsia: study protocol for a randomised controlled trial (PHOENIX trial).
Chappell LC. et al, (2019), Trials, 20
Enteral lactoferrin to prevent infection for very preterm infants: the ELFIN RCT.
Griffiths J. et al, (2018), Health Technol Assess, 22, 1 - 60
Ursodeoxycholic acid versus placebo in the treatment of women with intrahepatic cholestasis of pregnancy (ICP) to improve perinatal outcomes: protocol for a randomised controlled trial (PITCHES).
Chappell LC. et al, (2018), Trials, 19
Computerised analysis of intrapartum fetal heart rate patterns and adverse outcomes in the INFANT trial.
Steer PJ. et al, (2018), BJOG